Clinical Trial for Prostate Cancer Patients
The Edwards Comprehensive Cancer Center is taking part in a national clinical research study of an investigational prostate cancer immunotherapy.
This study team is seeking men with advance prostate cancer or physicians treating patients with metastatic hormone-refractory prostate cancer. A man may qualify to participate in this research study if:
- the cancer has spread to his bones or elsewhere in his body.
- he has been treated with hormone therapy and it has stopped working.
If you or someone you know has been treated with hormone therapy for metastatic hormone-refractory prostate cancer and are seeking information on clinical trial options, please call Dr. Maria Tirona at (304) 399-6617.
Page last updated: 05/19/2006 | Recommend this page | Printer friendly version